Female hormones and thrombosis

FR Rosendaal, FM Helmerhorst… - … , and vascular biology, 2002 - Am Heart Assoc
Exogenous hormones are used by more than a hundred million women worldwide as oral
contraceptives or for postmenopausal hormone replacement. Oral contraceptives increase …

Thrombotic risk factors: basic pathophysiology

I Martinelli, P Bucciarelli, PM Mannucci - Critical care medicine, 2010 - journals.lww.com
Although venous thrombosis has been traditionally associated with stasis and
hypercoagulability, arterial thrombosis is mainly associated with heightened platelet …

Low levels of tissue factor pathway inhibitor (TFPI) increase the risk of venous thrombosis

A Dahm, A van Hylckama Vlieg, B Bendz, F Rosendaal… - Blood, 2003 - ashpublications.org
There is now strong experimental evidence that tissue factor pathway inhibitor (TFPI) is a
critical inhibitor to modulate tissue factor–induced coagulation, but the role of TFPI as a risk …

Factor V and thrombotic disease: description of a janus-faced protein

GAF Nicolaes, B Dahlbäck - Arteriosclerosis, thrombosis, and …, 2002 - Am Heart Assoc
The generation of thrombin by the prothrombinase complex constitutes an essential step in
hemostasis, with thrombin being crucial for the amplification of blood coagulation, fibrin …

Venous thrombosis and changes of hemostatic variables during cross-sex hormone treatment in transsexual people

A Toorians, M Thomassen, S Zweegman… - The Journal of …, 2003 - academic.oup.com
The incidence of venous thrombosis associated with estrogen treatment in male-to-female
(M→ F) transsexuals is considerably higher with administration of oral ethinyl estradiol (EE) …

Metabolic effects of contraceptive steroids

R Sitruk-Ware, A Nath - Reviews in endocrine and metabolic disorders, 2011 - Springer
Estrogen and progestins have been used by millions of women as effective combined
contraceptives. The safety of hormonal contraceptives has been documented by years of …

Pharmacokinetics of inhaled nanotherapeutics for pulmonary delivery

AM Shen, T Minko - Journal of controlled release, 2020 - Elsevier
Pulmonary delivery of lipid-based nanotherapeutics by inhalation presents an
advantageous alternative to oral and intravenous routes of administration that avoids …

[HTML][HTML] The effects of obesity on venous thromboembolism: a review

G Yang, C De Staercke, WC Hooper - Open journal of preventive …, 2012 - ncbi.nlm.nih.gov
Obesity has emerged as a global health issue that is associated with wide spectrum of
disorders, including coronary artery disease, diabetes mellitus, hypertension, stroke, and …

Risk factors in venous thromboembolism

I Martinelli - Thrombosis and haemostasis, 2001 - thieme-connect.com
Venous thromboembolism is a serious disorder because of its potential complications, such
as pulmonary embolism and the post-thrombotic syndrome. Inherited determinants of …

[HTML][HTML] Estrogens, progestogens and thrombosis

FR Rosendaal, AVH Vlieg, BC Tanis… - Journal of Thrombosis …, 2003 - Elsevier
Hundreds of millions of women worldwide use either oral contraceptives or postmenopausal
hormone replacement. The use of oral contraceptives leads to an increased risk of venous …